condition found
Source: |
Type: |
Neuroprotective refers to the ability of a substance, intervention, or strategy to preserve the structure and function of nerve cells (neurons) against injury or degeneration. -While cancer and neurodegenerative processes might seem distinct, there is significant overlap in terms of treatment-related neurotoxicity, shared molecular mechanisms, and the potential for therapies that provide neuroprotection during cancer treatment. |
2558- | AL,  |   | Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment |
- | Review, | AD, | NA |
2645- | AL,  |   | Allicin improves endoplasmic reticulum stress-related cognitive deficits via PERK/Nrf2 antioxidative signaling pathway |
- | NA, | AD, | NA |
2656- | AL,  |   | Allicin Protects PC12 Cells Against 6-OHDA-Induced Oxidative Stress and Mitochondrial Dysfunction via Regulating Mitochondrial Dynamics |
- | in-vitro, | Park, | PC12 |
2657- | AL,  |   | Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases |
- | Review, | CardioV, | NA | - | Review, | AD, | NA |
2660- | AL,  |   | Allicin: A review of its important pharmacological activities |
- | Review, | AD, | NA | - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
2661- | AL,  |   | Allicin alleviates traumatic brain injury-induced neuroinflammation by enhancing PKC-δ-mediated mitophagy |
- | in-vivo, | Nor, | NA |
297- | ALA,  |   | Insights on the Use of α-Lipoic Acid for Therapeutic Purposes |
- | Review, | BC, | SkBr3 | - | Review, | neuroblastoma, | SK-N-SH | - | Review, | AD, | NA |
3444- | ALA,  |   | Alpha-Lipoic Acid Nootropic Review: Benefits, Use, Dosage & Side Effects |
- | Review, | NA, | NA |
3443- | ALA,  |   | Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3441- | ALA,  |   | α-Lipoic Acid Maintains Brain Glucose Metabolism via BDNF/TrkB/HIF-1α Signaling Pathway in P301S Mice |
- | in-vivo, | AD, | NA |
3440- | ALA,  |   | Protective effects of alpha lipoic acid (ALA) are mediated by hormetic mechanisms |
- | Review, | AD, | NA |
3438- | ALA,  |   | The Potent Antioxidant Alpha Lipoic Acid |
- | Review, | NA, | NA | - | Review, | AD, | NA |
3447- | ALA,  |   | Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells |
- | in-vitro, | AD, | SH-SY5Y |
3449- | ALA,  |   | Alpha-Lipoic Acid Downregulates IL-1β and IL-6 by DNA Hypermethylation in SK-N-BE Neuroblastoma Cells |
- | in-vitro, | AD, | SK-N-BE |
3539- | ALA,  |   | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
3543- | ALA,  |   | The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease |
- | Study, | AD, | NA |
3544- | ALA,  |   | Alpha lipoic acid for dementia |
- | Review, | AD, | NA |
3545- | ALA,  |   | Potential therapeutic effects of alpha lipoic acid in memory disorders |
- | Review, | AD, | NA |
3284- | ALA,  |   | Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson's Disease Model Induced by 6-OHDA |
- | vitro+vivo, | Park, | NA |
3271- | ALA,  |   | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
- | Review, | AD, | NA |
3270- | ALA,  |   | Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis |
- | Trial, | AD, | NA |
3547- | ALA,  |   | Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3549- | ALA,  |   | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
- | Review, | AD, | NA |
3550- | ALA,  |   | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
- | Review, | AD, | NA |
3551- | ALA,  |   | Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus |
- | in-vivo, | AD, | NA |
2636- | Api,  |   | Apigenin unveiled: an encyclopedic review of its preclinical and clinical insights |
- | Review, | NA, | NA |
1999- | Api,  | doxoR,  |   | Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation |
- | in-vitro, | Nor, | NRK52E | - | in-vitro, | Nor, | MPC5 | - | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
3159- | Ash,  |   | Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model |
- | in-vitro, | Park, | SH-SY5Y |
3161- | Ash,  |   | Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage |
- | in-vivo, | Stroke, | NA |
3166- | Ash,  |   | Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives |
- | Review, | Var, | NA |
2605- | Ba,  | BA,  |   | Potential therapeutic effects of baicalin and baicalein |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2609- | Ba,  |   | Baicalein: unveiling the multifaceted marvel of hepatoprotection and beyond |
- | Review, | NA, | NA |
2611- | Ba,  |   | Baicalein as a potent neuroprotective agent: A review |
- | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2623- | Ba,  |   | Activation of the Nrf2/HO-1 signaling pathway contributes to the protective effects of baicalein against oxidative stress-induced DNA damage and apoptosis in HEI193 Schwann cells |
- | in-vitro, | Nor, | HEI193 |
2626- | Ba,  |   | Molecular targets and therapeutic potential of baicalein: a review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
2614- | Ba,  |   | Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders |
- | Review, | NA, | NA |
2483- | Ba,  |   | Baicalein and 12/15-Lipoxygenase in the Ischemic Brain |
- | in-vivo, | Stroke, | NA |
2482- | Ba,  |   | Modulation of Neuroinflammation in Poststroke Rehabilitation: The Role of 12/15-Lipoxygenase Inhibition and Baicalein |
- | Review, | Stroke, | NA |
2673- | BBR,  |   | Therapeutic potential and recent delivery systems of berberine: A wonder molecule |
- | Review, | Var, | NA |
2678- | BBR,  |   | Berberine as a Potential Agent for the Treatment of Colorectal Cancer |
- | Review, | CRC, | NA |
2679- | BBR,  |   | Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress |
- | in-vivo, | AD, | NA |
2689- | BBR,  |   | Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells |
- | in-vitro, | Nor, | PC12 | - | in-vitro, | AD, | NA | - | in-vitro, | Stroke, | NA |
2724- | BetA,  |   | Down-regulation of NOX4 by betulinic acid protects against cerebral ischemia-reperfusion in mice |
- | in-vivo, | Nor, | NA | - | in-vivo, | Stroke, | NA |
2731- | BetA,  |   | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
- | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
696- | Bor,  |   | Nothing Boring About Boron |
- | Review, | Var, | NA |
3514- | Bor,  | CUR,  |   | Effects of Curcumin and Boric Acid Against Neurodegenerative Damage Induced by Amyloid Beta |
- | in-vivo, | AD, | NA |
3511- | Bor,  |   | Boron |
- | Review, | NA, | NA |
2775- | Bos,  |   | The journey of boswellic acids from synthesis to pharmacological activities |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
2772- | Bos,  |   | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
2768- | Bos,  |   | Boswellic acids as promising agents for the management of brain diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2794- | CHr,  |   | An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches |
- | Review, | Park, | NA | - | Review, | Stroke, | NA |
2781- | CHr,  | PBG,  |   | Chrysin a promising anticancer agent: recent perspectives |
- | Review, | Var, | NA |
2782- | CHr,  |   | Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2784- | CHr,  |   | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
- | Review, | Var, | NA |
2785- | CHr,  |   | Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin |
- | Review, | Var, | NA |
2788- | CHr,  |   | Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action |
- | Review, | Var, | NA |
2790- | CHr,  |   | Chrysin: Pharmacological and therapeutic properties |
- | Review, | Var, | NA |
- | Review, | AD, | NA |
2817- | CUR,  |   | Neuroprotection by curcumin: A review on brain delivery strategies |
- | Review, | Nor, | NA |
2816- | CUR,  |   | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3576- | CUR,  |   | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
1866- | DCA,  | MET,  | BTZ,  |   | Targeting metabolic pathways alleviates bortezomib-induced neuropathic pain without compromising anticancer efficacy in a sex-specific manner |
- | in-vivo, | NA, | NA |
2272- | dietMet,  |   | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
- | Review, | Nor, | NA |
3205- | EGCG,  |   | The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseas |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3201- | EGCG,  |   | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
- | Review, | NA, | NA |
3245- | EGCG,  |   | (−)-Epigallocatechin-3-gallate protects PC12 cells against corticosterone-induced neurotoxicity via the hedgehog signaling pathway |
- | in-vitro, | Nor, | PC12 |
2345- | EMD,  |   | Emodin ameliorates antioxidant capacity and exerts neuroprotective effect via PKM2-mediated Nrf2 transactivation |
- | in-vitro, | AD, | PC12 |
2845- | FIS,  |   | Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy |
- | Review, | Var, | NA |
2854- | FIS,  |   | New Perspectives for Fisetin |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
2861- | FIS,  |   | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2824- | FIS,  |   | Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics |
- | Review, | Var, | NA |
2827- | FIS,  |   | The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment |
- | Review, | Var, | NA |
2828- | FIS,  |   | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
- | Review, | Var, | NA |
2523- | H2,  |   | Prospects of molecular hydrogen in cancer prevention and treatment |
- | Review, | Var, | NA |
2519- | H2,  |   | Hydrogen: an advanced and safest gas option for cancer treatment |
- | Review, | Var, | NA |
2082- | HNK,  |   | Revealing the role of honokiol in human glioma cells by RNA-seq analysis |
- | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | U251 |
2894- | HNK,  |   | Pharmacological features, health benefits and clinical implications of honokiol |
- | Review, | Var, | NA | - | Review, | AD, | NA |
2890- | HNK,  |   | SIRT3 activation promotes enteric neurons survival and differentiation |
2899- | HNK,  |   | SIRT3 activator honokiol ameliorates surgery/anesthesia-induced cognitive decline in mice through anti-oxidative stress and anti-inflammatory in hippocampus |
- | in-vivo, | Nor, | NA |
2864- | HNK,  |   | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
- | Review, | Var, | NA |
2868- | HNK,  |   | Honokiol: A review of its pharmacological potential and therapeutic insights |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
2869- | HNK,  |   | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2872- | HNK,  |   | Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis |
- | in-vivo, | ALS, | NA | - | NA, | Stroke, | NA | - | NA, | AD, | NA | - | NA, | Park, | NA |
2873- | HNK,  |   | Honokiol Alleviates Oxidative Stress-Induced Neurotoxicity via Activation of Nrf2 |
- | in-vitro, | Nor, | PC12 |
2916- | LT,  |   | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2904- | LT,  |   | Luteolin from Purple Perilla mitigates ROS insult particularly in primary neurons |
- | in-vitro, | Park, | SK-N-SH | - | in-vitro, | AD, | NA |
2912- | LT,  |   | Luteolin: a flavonoid with a multifaceted anticancer potential |
- | Review, | Var, | NA |
1713- | Lyco,  |   | Lycopene: A Potent Antioxidant with Multiple Health Benefits |
- | Review, | Nor, | NA |
3528- | Lyco,  |   | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
- | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3532- | Lyco,  |   | Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease |
- | in-vitro, | AD, | NA |
3268- | Lyco,  |   | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
- | Review, | AD, | NA |
3264- | Lyco,  |   | Pharmacological potentials of lycopene against aging and aging‐related disorders: A review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
2544- | M-Blu,  |   | Methylene blue and its importance in medicine |
- | Review, | NA, | NA |
2545- | M-Blu,  |   | Reversing the Warburg Effect as a Treatment for Glioblastoma |
- | in-vitro, | GBM, | U87MG | - | NA, | AD, | NA | - | in-vitro, | GBM, | A172 | - | in-vitro, | GBM, | T98G |
2540- | M-Blu,  |   | Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots |
- | Review, | Var, | NA | - | Review, | AD, | NA |
1780- | MEL,  |   | Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing |
- | Review, | Var, | NA |
1776- | MEL,  |   | Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis |
- | Review, | NA, | NA |
2253- | MF,  |   | Low-frequency pulsed electromagnetic field promotes functional recovery, reduces inflammation and oxidative stress, and enhances HSP70 expression following spinal cord injury |
- | in-vivo, | Nor, | NA |
3475- | MF,  |   | A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells |
- | in-vitro, | Nor, | HT22 | - | Review, | AD, | NA |
3476- | MF,  |   | Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation |
- | in-vitro, | Stroke, | 1321N1 | - | in-vitro, | Park, | NA |
204- | MFrot,  |   | Rotating magnetic field improved cognitive and memory impairments in a sporadic ad model of mice by regulating microglial polarization |
- | in-vivo, | AD, | NA |
3488- | MFrot,  |   | Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway |
- | in-vivo, | AD, | NA |
3567- | MFrot,  |   | The Effect of Extremely Low-Frequency Magnetic Field on Stroke Patients: A Systematic Review |
- | Review, | Stroke, | NA |
2484- | mushLions,  |   | Neurotrophic and Neuroprotective Effects of Hericium erinaceus |
- | Review, | Stroke, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2936- | NAD,  |   | The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update |
2932- | NAD,  |   | Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment |
- | in-vitro, | Nor, | NA |
1798- | NarG,  |   | Naringenin: A potential flavonoid phytochemical for cancer therapy |
- | Review, | NA, | NA |
2031- | PB,  |   | Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model |
- | in-vivo, | AD, | NA |
2035- | PB,  |   | Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease |
- | in-vitro, | Nor, | glial | - | in-vivo, | NA, | NA |
2034- | PB,  |   | Protective effects of 4-phenylbutyrate derivatives on the neuronal cell death and endoplasmic reticulum stress |
- | in-vitro, | Nor, | SH-SY5Y |
2033- | PB,  |   | Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model |
- | in-vivo, | AD, | NA |
2032- | PB,  |   | Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice |
- | in-vivo, | AD, | NA |
2030- | PB,  |   | 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor |
- | Review, | Nor, | NA |
3249- | PBG,  |   | Can Propolis Be a Useful Adjuvant in Brain and Neurological Disorders and Injuries? A Systematic Scoping Review of the Latest Experimental Evidence |
- | Review, | Var, | NA |
3252- | PBG,  |   | Propolis Extract and Its Bioactive Compounds—From Traditional to Modern Extraction Technologies |
- | Review, | NA, | NA |
2963- | PL,  |   | Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease |
- | in-vitro, | AD, | HEK293 |
2999- | PL,  |   | Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation |
- | in-vivo, | Nor, | HUVECs |
2960- | PL,  |   | Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents |
- | Analysis, | Nor, | NA |
2950- | PL,  |   | Overview of piperlongumine analogues and their therapeutic potential |
- | Review, | Var, | NA |
2944- | PL,  |   | Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells |
- | in-vitro, | Thyroid, | IHH4 | - | in-vitro, | Thyroid, | 8505C | - | in-vivo, | NA, | NA |
3353- | QC,  |   | Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2/M-phase cell cycle arrest in KON oral cancer cells |
- | in-vitro, | Oral, | KON | - | in-vitro, | Nor, | MRC-5 |
3351- | QC,  |   | Quercetin Exerts Differential Neuroprotective Effects Against H2O2 and Aβ Aggregates in Hippocampal Neurons: the Role of Mitochondria |
- | Review, | AD, | NA |
3347- | QC,  |   | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3343- | QC,  |   | Quercetin, a Flavonoid with Great Pharmacological Capacity |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
3341- | QC,  |   | Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3380- | QC,  |   | Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases |
- | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
3374- | QC,  |   | Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis |
- | Review, | Oral, | NA | - | Review, | AD, | NA |
3367- | QC,  |   | Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments |
- | Review, | Stroke, | NA | - | Review, | AD, | NA |
3338- | QC,  |   | Quercetin: Its Antioxidant Mechanism, Antibacterial Properties and Potential Application in Prevention and Control of Toxipathy |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3336- | QC,  |   | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
2566- | RES,  |   | A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke |
- | Review, | Stroke, | NA |
2567- | RES,  |   | Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
- | Review, | Stroke, | NA |
2687- | RES,  |   | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | NA, | NA | - | Review, | AD, | NA |
2441- | RES,  |   | Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions |
- | Review, | Var, | NA |
3057- | RES,  |   | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3100- | RES,  |   | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3099- | RES,  |   | Resveratrol and cognitive decline: a clinician perspective |
- | Review, | Nor, | NA | - | NA, | AD, | NA |
3092- | RES,  |   | Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action |
- | Review, | BC, | MDA-MB-231 | - | Review, | BC, | MCF-7 |
3028- | RosA,  |   | Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease |
- | in-vitro, | AD, | HT22 | - | in-vivo, | NA, | NA |
3022- | RosA,  |   | Rosmarinic acid against cognitive impairment via RACK1/HIF-1α regulated microglial polarization in sepsis-surviving mice |
- | in-vitro, | Sepsis, | NA |
3014- | RosA,  |   | Rosmarinic Acid Supplementation Acts as an Effective Antioxidant for Restoring the Antioxidation/Oxidation Balance in Wistar Rats with Cadmium-Induced Toxicity |
- | in-vivo, | Nor, | NA |
3001- | RosA,  |   | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
- | Review, | Var, | NA |
3003- | RosA,  |   | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3006- | RosA,  |   | Rosmarinic acid attenuates glioblastoma cells and spheroids’ growth and EMT/stem-like state by PTEN/PI3K/AKT downregulation and ERK-induced apoptosis |
- | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 |
3007- | RosA,  |   | Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action |
- | Review, | NA, | NA |
3039- | RosA,  |   | Rosmarinic acid liposomes suppress ferroptosis in ischemic brain via inhibition of TfR1 in BMECs |
- | in-vivo, | Nor, | NA | - | in-vivo, | Stroke, | NA |
1745- | RosA,  |   | Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3182- | SFN,  |   | Sulforaphane Modulates AQP8-Linked Redox Signalling in Leukemia Cells |
- | in-vitro, | AML, | NA |
1724- | SFN,  |   | Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials |
- | Review, | Var, | NA |
1484- | SFN,  |   | Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3307- | SIL,  |   | Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications |
- | Review, | Var, | NA |
3288- | SIL,  |   | Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations |
- | Review, | Var, | NA |
3315- | SIL,  |   | Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats |
- | in-vivo, | Nor, | NA |
3294- | SIL,  |   | Silymarin: a review on paving the way towards promising pharmacological agent |
- | Review, | Nor, | NA | - | Review, | Arthritis, | NA |
3324- | SIL,  |   | Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage |
3331- | SIL,  |   | The clinical anti-inflammatory effects and underlying mechanisms of silymarin |
- | Review, | NA, | NA |
3330- | SIL,  |   | Mechanistic Insights into the Pharmacological Significance of Silymarin |
- | Review, | Var, | NA |
3321- | SIL,  |   | Silymarin (Milk thistle) |
- | Review, | AD, | NA |
3320- | SIL,  |   | Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action |
- | Review, | AD, | NA |
3319- | SIL,  |   | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3318- | SIL,  |   | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3317- | SIL,  |   | Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders |
- | Review, | NA, | NA |
3050- | SK,  |   | Systemic administration of Shikonin ameliorates cognitive impairment and neuron damage in NPSLE mice |
- | in-vivo, | Nor, | NA |
3040- | SK,  |   | Pharmacological Properties of Shikonin – A Review of Literature since 2002 |
- | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA |
3049- | SK,  |   | Shikonin Attenuates Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment by Inhibiting Apoptosis via PTEN/Akt/CREB/BDNF Signaling |
- | in-vivo, | Nor, | NA | - | NA, | Stroke, | NA |
2214- | SK,  |   | Shikonin Attenuates Cochlear Spiral Ganglion Neuron Degeneration by Activating Nrf2-ARE Signaling Pathway |
- | in-vitro, | Nor, | NA |
2213- | SK,  |   | Shikonin attenuates cerebral ischemia/reperfusion injury via inhibiting NOD2/RIP2/NF-κB-mediated microglia polarization and neuroinflammation |
- | in-vivo, | Stroke, | NA |
2126- | TQ,  |   | Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway |
- | Review, | Nor, | NA |
2122- | TQ,  |   | Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer |
- | Review, | Var, | NA |
2119- | TQ,  |   | Dual properties of Nigella Sativa: anti-oxidant and pro-oxidant |
- | Review, | Var, | NA |
2092- | TQ,  |   | Dissecting the Potential Roles of Nigella sativa and Its Constituent Thymoquinone on the Prevention and on the Progression of Alzheimer's Disease |
- | Review, | AD, | NA |
2100- | TQ,  |   | Dual properties of Nigella Sative: Anti-oxidant and Pro-oxidant |
- | Review, | NA, | NA |
- | in-vitro, | Nor, | SH-SY5Y |
3401- | TQ,  |   | Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review |
- | Review, | Var, | NA |
3410- | TQ,  |   | Anti-inflammatory effects of thymoquinone and its protective effects against several diseases |
- | Review, | Arthritis, | NA |
3432- | TQ,  |   | Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3404- | TQ,  |   | The Neuroprotective Effects of Thymoquinone: A Review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3408- | TQ,  |   | Thymoquinone: A small molecule from nature with high therapeutic potential |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3409- | TQ,  |   | Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives |
- | in-vivo, | Nor, | NA |
3553- | TQ,  |   | Study Effectiveness and Stability Formulation Nanoemulsion of Black Cumin Seed (Nigella sativa L.) Essential Oil: A Review |
- | Review, | Nor, | NA |
- | in-vivo, | AD, | NA |
3554- | TQ,  |   | Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons |
- | in-vitro, | AD, | NA |
3564- | TQ,  |   | The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer's Disease-like Condition: Mechanistic Insights |
- | in-vivo, | AD, | NA |
3563- | TQ,  |   | Thymoquinone (TQ) demonstrates its neuroprotective effect via an anti-inflammatory action on the Aβ(1–42)-infused rat model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3560- | TQ,  |   | Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes |
- | in-vivo, | AD, | NA |
3559- | TQ,  |   | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
2411- | UA,  |   | Ursolic acid in health and disease |
- | Review, | Var, | NA |
3102- | VitC,  |   | Two Faces of Vitamin C—Antioxidative and Pro-Oxidative Agent |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
2281- | VitK2,  |   | The biological responses of vitamin K2: A comprehensive review |
- | Review, | Var, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1105 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid